ATOXETIME 10

Description

ATOXETIME 10 contains Atomoxetine 10 mg, a selective norepinephrine reuptake inhibitor (NRI) used primarily for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children, adolescents, and adults. While not a traditional SSRI, it also exhibits benefits in improving mood, focus, and behavioral symptoms, often aiding patients with depression or comorbid anxiety disorders. Unlike stimulant-based therapies, Atomoxetine provides sustained symptom control without causing dependence or insomnia.

ATOXETIME 10 works by increasing norepinephrine levels in the brain, enhancing attention span, reducing impulsivity, and improving emotional regulation. It is well-suited for long-term therapy and has a favorable safety profile when taken under medical supervision. With its non-stimulant nature, once-daily oral administration, and reliable therapeutic effects, ATOXETIME 10 is an effective solution for managing cognitive and emotional imbalance.